Belimumab for systemic lupus erythematosus – Focus on lupus nephritis

In recent years, advances in the treatment and management of patients with systemic lupus erythematosus (SLE) have improved their life expectancy and quality of life. However, lupus nephritis (LN) still represents a major life-threatening complication of the disease. Belimumab (BEL), a fully human m...

Descripción completa

Detalles Bibliográficos
Autores principales: Plüß, Marlene, Piantoni, Silvia, Tampe, Björn, Kim, Alfred H. J., Korsten, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Immunotherapeutics – Product Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359396/
https://www.ncbi.nlm.nih.gov/pubmed/35588699
http://dx.doi.org/10.1080/21645515.2022.2072143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359396/
https://www.ncbi.nlm.nih.gov/pubmed/35588699
http://dx.doi.org/10.1080/21645515.2022.2072143

Ejemplares similares